Strategy and innovation leading the PBM industry

At Prime, our success is determined by our ability to assess the critical role that PBMs play in today's dynamically changing health care landscape; and to respond, with strategy and purpose, to the shifting needs of our clients, employer groups and members.

Follow us in the media and read about the important issues facing us today and what we're doing to address them.

Recent News

Prime Therapeutics urges FDA to keep current, consistent naming conventions for biologics, biosimilars (September 8, 2014)

Prime Therapeutics' 2013 overall net cost per prescription of $58.99 is industry-low for third consecutive year (June 17, 2014)

Prime Therapeutics' Controlled Substance Drug Utilization Review program wins Case in Point Platinum Award in the Disease Management/Population Health category (May 14, 2014)

Prime Therapeutics ranks highest in customer satisfaction for two consecutive years (April 29, 2014)

Prime Therapeutics Patrick Gleason receives Academy of Managed Care Pharmacy Spirit of Volunteerism Award (April 4, 2014)

Media Release Archive

Access our archive of media releases.




Media Contact

Contact us for more information or with any media queries.

Prime at a Glance

Download our corporate snapshot.